Eclipse Life Sciences Reports Positive Phase 2 Drug Data
The company showed improvement in key vision metrics for its EC-104 corticosteroid implant in a recent clinical trial.
Live Poll
Do you believe medical treatments for chronic conditions like vision loss are becoming more manageable?